Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EI24 pseudogene 1 (EI24P1) is classified as a pseudogene related to the functional EI24 gene, which encodes a transmembrane protein involved in autophagy and cell death—biological processes relevant to tumor suppression and cancer biology[7]. Pseudogenes like EI24P1 do not produce functional protein products and are generally considered non-coding genomic elements. Unlike the parent gene EI24, EI24P1 plays no direct role in cell signaling, autophagy, apoptosis, or disease, and is not considered a therapeutic, diagnostic, or drug target in biomedical research or clinical practice[7][4]. Any reference to drug interactions, safety, or function should properly refer to the parental functional gene EI24, not to the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EI24 pseudogene 1 (EI24P1).